Nursing and midwifery practice for maintenance of vascular access device patency. A cross-sectional survey.

[1]  D. Macklin.  What's Physics Got To Do With It? A Review of the Physical Principles of Fluid Administration , 2019 .

[2]  L. Ronfani,et al.  Normal saline flushes performed once daily maintain peripheral intravenous catheter patency: a randomised controlled trial , 2015, Archives of Disease in Childhood.

[3]  P. Scuffham,et al.  Cost-Effectiveness Analysis of Clinically Indicated Versus Routine Replacement of Peripheral Intravenous Catheters , 2014, Applied Health Economics and Health Policy.

[4]  D. Palombo,et al.  Pre-filled normal saline syringes to reduce totally implantable venous access device-associated bloodstream infection: a single institution pilot study. , 2013, The Journal of hospital infection.

[5]  M. Wallis,et al.  Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial , 2012, The Lancet.

[6]  D. Prentice,et al.  National survey of central venous catheter flushing in the intensive care unit. , 2012, Critical care nurse.

[7]  J. Timsit,et al.  New materials and devices for preventing catheter-related infections , 2011, Annals of intensive care.

[8]  J. Timsit,et al.  New challenges in the diagnosis, management, and prevention of central venous catheter-related infections. , 2011, Seminars in respiratory and critical care medicine.

[9]  A. Jiménez-Sosa,et al.  Comparative Safety and Costs of Transparent Versus Gauze Wound Dressings in Intravenous Catheterization , 2011, Journal of nursing care quality.

[10]  J. Bae.  Insertion and Management of Central Venous Catheters , 2011 .

[11]  C. Lefaiver,et al.  A Randomized Controlled Trial to Compare the Complications of 2 Peripheral Intravenous Catheter-Stabilization Systems , 2010, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[12]  M. McGrail,et al.  Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial , 2010, BMC medicine.

[13]  Michael P Hewson,et al.  A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: the Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[14]  F. N. Dias,et al.  Benefits of Establishing an Intravenous Team and the Standardization of Peripheral Intravenous Catheters , 2010, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[15]  C. Pui,et al.  Management of occlusion and thrombosis associated with long-term indwelling central venous catheters , 2009, The Lancet.

[16]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  D. Maki,et al.  Intravascular catheter-related infections: advances in diagnosis, prevention, and management. , 2007, The Lancet. Infectious diseases.

[18]  L. Gorski.  Infusion nursing standards of practice. , 2007, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[19]  Michael B Edmond,et al.  Team-based prevention of catheter-related infections. , 2006, The New England journal of medicine.

[20]  Dan M. Kluger,et al.  The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. , 2006, Mayo Clinic proceedings.

[21]  L. Hadaway.  Technology of Flushing Vascular Access Devices , 2006, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[22]  S. Campbell,et al.  How Often Should Peripheral Intravenous Catheters in Ambulatory Patients Be Flushed? , 2005, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[23]  M. Hsairi,et al.  Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  G. O’Toole,et al.  Heparin Stimulates Staphylococcus aureus Biofilm Formation , 2005, Infection and Immunity.

[25]  E. Wong,et al.  Prevalence of the Use of Central Venous Access Devices Within and Outside of the Intensive Care Unit: Results of a Survey Among Hospitals in the Prevention Epicenter Program of the Centers for Disease Control and Prevention , 2003, Infection Control & Hospital Epidemiology.

[26]  R. Griffiths,et al.  Peripheral Venous Catheters: A Review of Current Practices , 2003, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[27]  I. Raad,et al.  In Vitro and Ex Vivo Activities of Minocycline and EDTA against Microorganisms Embedded in Biofilm on Catheter Surfaces , 2003, Antimicrobial Agents and Chemotherapy.

[28]  J. Costerton,et al.  Antimicrobial Activity of a Novel Catheter Lock Solution , 2002, Antimicrobial Agents and Chemotherapy.

[29]  O. Cornely,et al.  Peripheral Teflon Catheters: Factors Determining Incidence of Phlebitis and Duration of Cannulation , 2002, Infection Control & Hospital Epidemiology.

[30]  W. Tan,et al.  Reducing Infusion Phlebitis in Singapore Hospitals Using Extended Life End-Line Filters , 2002, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[31]  I. Raad,et al.  Efficacy of Minocycline and EDTA Lock Solution in Preventing Catheter-Related Bacteremia, Septic Phlebitis, and Endocarditis in Rabbits , 2002, Antimicrobial Agents and Chemotherapy.

[32]  A. Wade,et al.  Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children , 2000, Intensive Care Medicine.

[33]  Homer Ld,et al.  Risks associated with 72- and 96-hour peripheral intravenous catheter dwell times. , 1998 .

[34]  D. Cook,et al.  Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials , 1998, British medical journal.

[35]  T. Bregenzer,et al.  Is routine replacement of peripheral intravenous catheters necessary? , 1998, Archives of internal medicine.

[36]  R. Staugas,et al.  Peripheral Intravenous Line Survival and Phlebitis Prevention in Patients Receiving Intravenous Antibiotics: Heparin/Hydrocortisone versus In-Line Filters , 1994 .

[37]  D. Ones,et al.  A Meta‐Analysis of Effects of Heparin Flush and Saline Flush: Quality and Cost Implications , 1991, Nursing research.

[38]  K. Kirchhoff,et al.  Analysis of the research about heparinized versus nonheparinized intravascular lines. , 1991, Heart & lung : the journal of critical care.

[39]  M. Ringer,et al.  Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. , 1991, Annals of internal medicine.

[40]  Sebastian Fischer,et al.  Infusion Nursing An Evidence Based Approach , 2016 .

[41]  Jolene L Johnson.  What’s Physics Got to Do with It? , 2013 .

[42]  D. Bolton.  Improving peripheral cannulation practice at an NHS Trust. , 2010, British journal of nursing.

[43]  T. Royer.  Improving Short Peripheral IV Outcomes: A Clinical Trial of Two Securement Methods , 2003 .

[44]  White Sa.  Peripheral intravenous therapy-related phlebitis rates in an adult population. , 2001 .

[45]  S. White.  Peripheral intravenous therapy-related phlebitis rates in an adult population. , 2001, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.

[46]  L. Homer,et al.  Risks associated with 72- and 96-hour peripheral intravenous catheter dwell times. , 1998, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.

[47]  Analysis of Research , 1972, Nature.